BEAUTYFARM MED (02373) Schedules 27 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal

Bulletin Express

昨天

Beauty Farm Medical and Health Industry Inc. (stock code: 02373) will convene its board of directors in Hong Kong on Friday, 27 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025 and to consider a final-dividend recommendation.

Following board approval, the audited annual results will be released on the company’s investor-relations website (https://ir.beautyfarm.com.cn) and on the HKEX news website (www.hkexnews.hk).

Management will host an earnings conference call on the same day at 3:00 p.m. Hong Kong time. Investors may register in advance via the meeting link (https://s.comein.cn/h7qn5yks) using passcode 384138.

The board currently comprises one chairman and executive director, one vice-chairman and executive director, three non-executive directors and three independent non-executive directors, as detailed in the announcement dated 13 March 2026.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1173085176"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1173085176\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1173085176?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-13 19:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173085176","market":"hk","top_or_hot":-1,"title":"BEAUTYFARM MED (02373) Schedules 27 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal","media":"Bulletin Express","content":"<p>Beauty Farm Medical and Health Industry Inc. (stock code: 02373) will convene its board of directors in Hong Kong on Friday, 27 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025 and to consider a final-dividend recommendation.</p>\n<p>Following board approval, the audited annual results will be released on the company’s investor-relations website (https://ir.beautyfarm.com.cn) and on the HKEX news website (www.hkexnews.hk).</p>\n<p>Management will host an earnings conference call on the same day at 3:00 p.m. Hong Kong time. Investors may register in advance via the meeting link (https://s.comein.cn/h7qn5yks) using passcode 384138.</p>\n<p>The board currently comprises one chairman and executive director, one vice-chairman and executive director, three non-executive directors and three independent non-executive directors, as detailed in the announcement dated 13 March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BEAUTYFARM MED (02373) Schedules 27 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBEAUTYFARM MED (02373) Schedules 27 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-13 19:23</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Beauty Farm Medical and Health Industry Inc. (stock code: 02373) will convene its board of directors in Hong Kong on Friday, 27 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025 and to consider a final-dividend recommendation.</p>\n<p>Following board approval, the audited annual results will be released on the company’s investor-relations website (https://ir.beautyfarm.com.cn) and on the HKEX news website (www.hkexnews.hk).</p>\n<p>Management will host an earnings conference call on the same day at 3:00 p.m. Hong Kong time. Investors may register in advance via the meeting link (https://s.comein.cn/h7qn5yks) using passcode 384138.</p>\n<p>The board currently comprises one chairman and executive director, one vice-chairman and executive director, three non-executive directors and three independent non-executive directors, as detailed in the announcement dated 13 March 2026.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02373","symbol_name":"美麗田園醫療健康","start_time":0,"source_url":"","article_id":"1173085176","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173085176","pubTimestamp":1773401026,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Beauty Farm Medical and Health Industry Inc. (stock code: 02373) will convene its board of directors in Hong Kong on Friday, 27 March 2026 to review and approve the consolidated financial results for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02373":"美丽田园医疗健康"},"translate_title":"BEAUTYFARM MED(02373)定于2026年3月27日召开董事会，批准2025财年业绩和末期股息提案","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02373":1},"content_text":"Beauty Farm Medical and Health Industry Inc. (stock code: 02373) will convene its board of directors in Hong Kong on Friday, 27 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025 and to consider a final-dividend recommendation.\nFollowing board approval, the audited annual results will be released on the company’s investor-relations website (https://ir.beautyfarm.com.cn) and on the HKEX news website (www.hkexnews.hk).\nManagement will host an earnings conference call on the same day at 3:00 p.m. Hong Kong time. Investors may register in advance via the meeting link (https://s.comein.cn/h7qn5yks) using passcode 384138.\nThe board currently comprises one chairman and executive director, one vice-chairman and executive director, three non-executive directors and three independent non-executive directors, as detailed in the announcement dated 13 March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}